title: Strategies and developments of immunotherapies in osteosarcoma.
abstract: Osteosarcoma (OS) is a frequently observed primary malignant tumor. Current therapy for osteosarcoma consists of comprehensive treatment. The long-term survival rate of patients exhibiting nonmetastatic OS varies between 65-70%. However, a number of OS cases have been observed to be resistant to currently used therapies, leading to disease recurrence and lung metastases, which are the primary reasons leading to patient mortality. In the present review, a number of pieces of evidence provide support for the potential uses of immunotherapy, including immunomodulation and vaccine therapy, for the eradication of tumors via upregulation of the immune response. Adoptive T-cell therapy and oncolytic virotherapy have been used to treat OS and resulted in objective responses. Immunologic checkpoint blockade and targeted therapy are also potentially promising therapeutic tools. Immunotherapy demonstrates significant promise with regard to improving the outcomes for patients exhibiting OS.
authors.affiliation: Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
authors.forename: Jia
authors.initials: J
authors.lastname: Wan
authors.affiliation: Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
authors.forename: Xianghong
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
authors.forename: Tang
authors.initials: T
authors.lastname: Liu
authors.affiliation: Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
authors.forename: Xiangsheng
authors.initials: X
authors.lastname: Zhang
keywords: adoptive T-cell immunotherapy; immunologic checkpoint blockade; immunomodulation; immunotherapy; oncolytic virotherapy; osteosarcoma; targeted therapy; vaccines
references.citation: Nat Rev Immunol. 2009 Aug;9(8):568-80
references.pmid: 19629084
references.citation: Int J Cancer. 1977 Apr 15;19(4):468-73
references.pmid: 265297
references.citation: Lancet Oncol. 2010 Feb;11(2):155-64
references.pmid: 20004617
references.citation: J Clin Oncol. 2008 Feb 1;26(4):633-8
references.pmid: 18235123
references.citation: Clin Orthop Relat Res. 2001 Jan;(382):59-65
references.pmid: 11154005
references.citation: J Immunother. 2013 Feb;36(2):133-51
references.pmid: 23377668
references.citation: Pediatr Blood Cancer. 2014 Aug;61(8):1362-8
references.pmid: 24610870
references.citation: DNA Cell Biol. 2011 Dec;30(12):1051-5
references.pmid: 21612409
references.citation: Pediatr Blood Cancer. 2010 Mar;54(3):350-4
references.pmid: 19902521
references.citation: Cancer. 2002 Jul 15;95(2):389-96
references.pmid: 12124839
references.citation: J Clin Oncol. 2005 Mar 20;23(9):2004-11
references.pmid: 15774791
references.citation: Acta Oncol. 1995;34(6):877-80
references.pmid: 7576758
references.citation: Pediatr Transplant. 2009 Sep;13(6):746-53
references.pmid: 19067917
references.citation: Cancer Gene Ther. 2014 Aug;21(8):340-8
references.pmid: 25034886
references.citation: Clin Cancer Res. 2012 Jan 15;18(2):432-41
references.pmid: 22090361
references.citation: Oncoimmunology. 2012 Jul 1;1(4):458-466
references.pmid: 22754764
references.citation: Clin Cancer Res. 2010 Aug 1;16(15):3901-9
references.pmid: 20542985
references.citation: Science. 2006 Oct 6;314(5796):126-9
references.pmid: 16946036
references.citation: Postepy Hig Med Dosw. 1997;51(2):227-36
references.pmid: 9235567
references.citation: Cytotherapy. 2003;5(3):259-72
references.pmid: 12850795
references.citation: Cancer Res. 2013 Mar 15;73(6):1777-86
references.pmid: 23302231
references.citation: Cancer Sci. 2012 Sep;103(9):1625-30
references.pmid: 22726592
references.citation: Tumori. 2003 May-Jun;89(3):263-8
references.pmid: 12908780
references.citation: J Clin Oncol. 2010 Jul 1;28(19):3167-75
references.pmid: 20516446
references.citation: Clin Cancer Res. 2000 Mar;6(3):798-806
references.pmid: 10741699
references.citation: Sarcoma. 2011;2011:438940
references.pmid: 21331153
references.citation: Mol Ther. 2011 Mar;19(3):620-6
references.pmid: 21157437
references.citation: J Virol. 2006 Feb;80(3):1110-20
references.pmid: 16414988
references.citation: N Engl J Med. 2012 Jun 28;366(26):2443-54
references.pmid: 22658127
references.citation: Tumour Biol. 2014 Sep;35(9):8771-9
references.pmid: 24874050
references.citation: Nat Rev Clin Oncol. 2011 Aug 02;8(10):577-85
references.pmid: 21808266
references.citation: Cancer. 2009 Nov 15;115(22):5339-48
references.pmid: 19637348
references.citation: Cell Death Dis. 2013 Oct 24;4:e874
references.pmid: 24157868
references.citation: Acta Oncol. 2005;44(5):475-80
references.pmid: 16118081
references.citation: Genet Test Mol Biomarkers. 2011 Jul-Aug;15(7-8):503-6
references.pmid: 21453059
references.citation: Br J Cancer. 2005 Apr 25;92(8):1358-65
references.pmid: 15798769
references.citation: Oncogene. 2000 Jan 6;19(1):2-12
references.pmid: 10644974
references.citation: Clin Cancer Res. 2005 Jan 1;11(1):67-72
references.pmid: 15671529
references.citation: Immunol Rev. 2014 Jan;257(1):14-38
references.pmid: 24329787
references.citation: Nat Biotechnol. 2012 Jul 10;30(7):658-70
references.pmid: 22781695
references.citation: Cancer Biother Radiopharm. 2004 Oct;19(5):581-8
references.pmid: 15650450
references.citation: Cancer Res. 2003 Aug 1;63(15):4434-40
references.pmid: 12907616
references.citation: Mol Ther. 2010 Apr;18(4):843-51
references.pmid: 20179677
references.citation: J Pediatr Hematol Oncol. 2002 Aug-Sep;24(6):447-53
references.pmid: 12218591
references.citation: J Biol Chem. 2004 Mar 12;279(11):10304-15
references.pmid: 14701802
references.citation: Sarcoma. 2013;2013:168145
references.pmid: 23554566
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3352-6
references.pmid: 9096397
references.citation: Blood. 2013 Aug 8;122(6):863-71
references.pmid: 23770775
references.citation: PLoS One. 2013 Dec 11;8(12):e82870
references.pmid: 24349382
references.citation: Anticancer Res. 2012 Mar;32(3):779-82
references.pmid: 22399592
references.citation: Cytotherapy. 2013 Dec;15(12):1563-70
references.pmid: 24094496
references.citation: J Immunother Emphasis Tumor Immunol. 1995 Apr;17 (3):181-93
references.pmid: 7613644
references.citation: Cancer Immunol Immunother. 2009 Dec;58(12 ):1991-2001
references.pmid: 19360406
references.citation: PLoS One. 2013 Apr 23;8(4):e61895
references.pmid: 23626745
references.citation: Nat Rev Immunol. 2012 Mar 22;12(4):269-81
references.pmid: 22437939
references.citation: Int J Oncol. 2009 Oct;35(4):741-9
references.pmid: 19724910
references.citation: Discov Med. 2010 Oct;10(53):293-304
references.pmid: 21034670
references.citation: Clin Cancer Res. 2013 Mar 1;19(5):1021-34
references.pmid: 23460533
references.citation: Clin Cancer Res. 2010 Aug 1;16(15):4024-30
references.pmid: 20576718
references.citation: J Clin Oncol. 2011 Mar 1;29(7):917-24
references.pmid: 21282551
references.citation: Nat Rev Cancer. 2008 Apr;8(4):299-308
references.pmid: 18354418
references.citation: Ann Oncol. 2005 Jul;16(7):1199-206
references.pmid: 15849223
references.citation: Science. 1994 Dec 23;266(5193):2011-5
references.pmid: 7605428
references.citation: Pediatr Blood Cancer. 2014 Apr;61(4):618-26
references.pmid: 24136885
references.citation: Genet Test Mol Biomarkers. 2014 Aug;18(8):574-9
references.pmid: 25000484
references.citation: J Clin Oncol. 2002 Sep 15;20(18):3841-9
references.pmid: 12228203
references.citation: Clin Cancer Res. 2008 Aug 1;14(15):4850-8
references.pmid: 18676758
references.citation: N Engl J Med. 2013 Jul 11;369(2):134-44
references.pmid: 23724846
references.citation: Int J Oncol. 2004 Feb;24(2):365-72
references.pmid: 14719113
references.citation: Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):924-32
references.pmid: 21398051
references.citation: Cancer Res. 2012 Jan 1;72(1):271-81
references.pmid: 22075555
references.citation: Clin Cancer Res. 2004 Aug 15;10(16):5299-312
references.pmid: 15328165
references.citation: Oncol Rep. 2006 Mar;15(3):693-700
references.pmid: 16465432
references.citation: N Engl J Med. 2011 Jun 30;364(26):2517-26
references.pmid: 21639810
references.citation: Blood. 2012 Jan 19;119(3):696-706
references.pmid: 22117050
references.citation: Nat Biotechnol. 2002 Jan;20(1):70-5
references.pmid: 11753365
references.citation: Discov Med. 2014 Apr;17(94):201-6
references.pmid: 24759624
references.citation: Clin Cancer Res. 1999 Sep;5(9):2316-23
references.pmid: 10499599
references.citation: Int Immunopharmacol. 2014 Dec;23(2):499-504
references.pmid: 25284343
references.citation: Science. 1996 Oct 18;274(5286):373-6
references.pmid: 8832876
references.citation: Cancer Sci. 2006 Dec;97(12):1374-80
references.pmid: 16995877
references.citation: Cancer Res. 1985 Nov;45(11 Pt 2):5598-602
references.pmid: 3863709
references.citation: Oncogene. 2005 Sep 8;24(40):6069-79
references.pmid: 16155595
references.citation: Eur J Cancer. 1997 Apr;33(5):787-91
references.pmid: 9282118
references.citation: Clin Cancer Res. 2004 Jan 1;10 (1 Pt 1):61-7
references.pmid: 14734452
references.citation: Cancer Res. 2011 Jul 1;71(13):4617-27
references.pmid: 21546571
references.citation: Immunol Today. 1990 Jul;11(7):237-44
references.pmid: 2201309
references.citation: Am J Clin Oncol. 1995 Apr;18(2):93-9
references.pmid: 7900714
references.citation: J Exp Clin Cancer Res. 2014 Mar 10;33:27
references.pmid: 24612598
references.citation: Sarcoma. 2014;2014:391967
references.pmid: 24778572
references.citation: Cancer Gene Ther. 2009 Feb;16(2):126-36
references.pmid: 18818710
references.citation: Clin Cancer Res. 2013 Oct 15;19(20):5636-46
references.pmid: 23873688
references.citation: Curr Oncol Rep. 2002 Nov;4(6):510-4
references.pmid: 12354364
references.citation: APMIS. 2015 Feb;123(2):102-7
references.pmid: 25257510
references.citation: Cancer Gene Ther. 2012 Mar;19(3):212-7
references.pmid: 22173710
references.citation: J Natl Cancer Inst. 1989 Jun 21;81(12 ):935-8
references.pmid: 2733037
references.citation: Hum Gene Ther. 2001 Aug 10;12(12):1591-3
references.pmid: 11529247
references.citation: J Cancer Res Clin Oncol. 2011 Jun;137(6):1037-51
references.pmid: 21193997
references.citation: Med Wieku Rozwoj. 2012 Jul-Sep;16(3):212-21
references.pmid: 23378399
references.citation: Cancer Biother Radiopharm. 2009 Apr;24(2):261-9
references.pmid: 19409049
references.citation: Adv Exp Med Biol. 2014;804:259-83
references.pmid: 24924179
references.citation: Pediatr Blood Cancer. 2014 Feb;61(2):238-44
references.pmid: 23997016
references.citation: J Gene Med. 2006 Jun;8(6):679-89
references.pmid: 16570242
references.citation: Adv Exp Med Biol. 2014;804:323-40
references.pmid: 24924183
references.citation: Curr Opin Investig Drugs. 2010 Dec;11(12):1354-9
references.pmid: 21154117
references.citation: Technol Cancer Res Treat. 2015 Aug;14(4):369-78
references.pmid: 25326586
references.citation: Pediatr Blood Cancer. 2010 Dec 15;55(7):1300-5
references.pmid: 20981688
references.citation: Ther Clin Risk Manag. 2010 Jun 24;6:279-86
references.pmid: 20596505
references.citation: Sci China Life Sci. 2013 Apr;56(4):298-305
references.pmid: 23564184
references.citation: Eur J Histochem. 2003;47(4):309-16
references.pmid: 14706926
references.citation: Int Immunol. 2005 Feb;17(2):133-44
references.pmid: 15611321
references.citation: ISRN Obstet Gynecol. 2014 Mar 11;2014:323657
references.pmid: 25006480
references.citation: J Surg Res. 2012 Jun 15;175(2):e53-60
references.pmid: 22341347
references.citation: J Transl Med. 2014 Jul 09;12 :191
references.pmid: 25008236
references.citation: Cancer Treat Res. 2009;152:447-57
references.pmid: 20213407
references.citation: J Bone Miner Res. 2014 Oct;29(10 ):2287-96
references.pmid: 24737304
references.citation: Hum Gene Ther. 2005 Aug;16(8):937-46
references.pmid: 16076252
references.citation: Cancer Res. 1990 Dec 15;50(24):7950-4
references.pmid: 2253237
references.citation: Blood. 2009 Jul 16;114(3):535-46
references.pmid: 19451549
references.citation: Pediatr Blood Cancer. 2010 Dec 1;55(6):1096-102
references.pmid: 20734401
references.citation: Semin Respir Crit Care Med. 2011 Aug;32(4):494-511
references.pmid: 21858752
references.citation: Mol Ther. 2009 Oct;17(10):1779-87
references.pmid: 19532139
references.citation: Expert Opin Investig Drugs. 2008 Jul;17(7):1105-13
references.pmid: 18549346
references.citation: Rev Recent Clin Trials. 2008 Sep;3(3):228-31
references.pmid: 18782081